Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsAuthors Retract Studies That Found Risks of Antimalaria Drugs for Covid-19
https://www.wsj.com/articles/authors-retract-study-that-found-risks-of-using-antimalaria-drug-against-covid-19-11591299329Two major studies casting doubt on the ability of antimalaria drugs to treat Covid-19 patients based on data from a little-known Chicago company, Surgisphere Corp., were retracted Thursday.
The Lancet first pulled a study published late last month that found antimalarials provided no benefit as a treatment for Covid-19 infections while increasing the risk of heart problems and death. The New England Journal of Medicine then retracted a separate article, published in early May, that examined the impact of cardiovascular and blood-pressure drugs in Covid-19 patients.
Both articles featured three of the same authors, Mandeep Mehra, Amit Patel and Sapan Desai, and were based on data supplied by Dr. Desais company, Surgisphere.
Surgisphere had said it collected the de-identified patient information from hospitals that was used in the studies. The Wall Street Journal contacted more than a dozen large U.S. hospitals, including some that treated high numbers of Covid-19 patients. None said they had an arrangement to share patient data with Surgisphere, and several said they had never heard of it.
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
5 replies, 889 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (4)
ReplyReply to this post
5 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Authors Retract Studies That Found Risks of Antimalaria Drugs for Covid-19 (Original Post)
Kilgore
Jun 2020
OP
Those weren't double blind studies. When those are conducted, we will see if there
still_one
Jun 2020
#1
still_one
(92,219 posts)1. Those weren't double blind studies. When those are conducted, we will see if there
is any merit to it or not
I'm constantly amazed how much crappy info is out there.
Totally useless.
"The biggest clinical trials to test the efficacy of hydroxychloroquine as a COVID-19 treatment has been stopped by the United Kingdom as no benefit was found. The trial run by the University of Oxford has stopped enrolling patients with immediate effect saying hydroxychloroquine does not benefit hospitalised COVID-19 patients and it did not reduce the risk of death."
https://www.cnbctv18.com/healthcare/uk-halts-trial-of-hydroxychloroquine-as-useless-for-coronavirus-patients-6082861.htm
still_one
(92,219 posts)5. This study I was unaware of, and it looks like it was done correctly